Interstitial pneumonitis is a frequent complication in liver transplant recipients treated with sirolimus

Irish Journal of Medical Science

Volumn 181, Issue 2, 2012, Pages 231-235

  Morcos, A ^a   Nair, S ^a   Keane, M P ^a,b   McElvaney, N G ^c,d   McCormick, P A ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Liver transplantation; MTOR inhibitors; Pneumonia; Pneumonitis

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT ATRESIA; BRONCHOSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EARLY DIAGNOSIS; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; KIDNEY GRAFT REJECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG LAVAGE; MALE; NEPHROTOXICITY; ORGAN TRANSPLANTATION; THORAX RADIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SIROLIMUS; TIME FACTORS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84864284947     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-011-0789-y     Document Type: Article

References (19)

1. Toso C, Merani S, Bigam DL, Shapiro AMJ, Kneteman NM (2010) Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology 51:1237-1243
2. Lennon A, Finan K, Fitzgerald MX, McCormick PA (2001) Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation. Transplantation 72:1166-1167 (Pubitemid 32924098)
3. Morelon E, Stern M, Kreis H (2000) Interstitial pneumonitis associated with sirolimus therapy in renal transplant recipients. N Eng J Med 343:225-236
4. Roberts RJ, Wells AC, Unitt E et al (2007) Sirolimus-induced pneumonitis following liver transplantation. Liver Transpl 13(6): 853-856 (Pubitemid 46939439)
5. Shrestha NK, Mossad SB, Braun W (2003) Pneumonitis associated with the use of mycophenolate mofetil. Transplantation 75: 1762 (Pubitemid 36629166)
6. Errasti P, Izquierdo D, Martin P et al (2010) Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-centre experience. Transpl Proc 42: 3053-3054
7. Schrader J, Sterneck M, Klose H, Lohse AW, Nashan B, Fischer L (2010) Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options. Transpl Int 23:110-113
8. Delgado JF, Torres J, Jose Ruiz-Cano M et al (2006) Sirolimusassociated interstitial pneumonitis in 3 heart transplant recipients. J Heart Lung Transpl 25:1171-1174 (Pubitemid 44311530)
9. McWilliams TJ, Lewey BJ, Russell PA, Milne DG, Snell GI (2003) Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation. J Heart Lung Transplant 22: 210-213 (Pubitemid 36173681)
10. Rodriguez-Pascual J, Cheng E, Maroto P, Duran I (2010) Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma. Anticancer Drugs 21: 478-486
11. Avitzur Y, Jimenez-Rivera C, Fecteau A, Jones N, Ngan Bo Y, Ng VL (2003) Interstitial granulomatous pneumonitis associated with sirolimus in a child after liver transplantation. J Paediatr Gastroenterol Nutr 37:91-94 (Pubitemid 39274576)
12. Perez MJ, Martin RO, Garcia DM, Rey JM, de la Cruz Lombardo, Rodrigo Lopez JM (2007) Interstitial pneumonitis associated with sirolimus in liver transplantation: a case report. Transpl Proc 39:3498-3499 (Pubitemid 350251453)
13. De Simone P, Petruccelli S, Precisi A et al (2007) Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipients-not all proliferation signal inhibitors are the same: a case report. Transpl Proc 39:3500-3501 (Pubitemid 350251514)
14. Nocera A, Androno E, Tagliamacco A et al (2008) Sirolimus therapy in liver transplant patients: an initial experience at a single center. Transpl Proc 40:1950-1952
15. Rivero M, Crespo L, Arranz G et al (2009) Bronchiolitis obliterans with organizing pneumonia in a patient after liver transplantation. Rev Esp Enferm Dig 101:583-584
16. Feagans J, Victor D, Moehlen M et al (2009) Interstitial pneumonitis in the transplant patient: consider sirolimus-associated pulmonary toxicity. J La State Med Soc 161:166-172
17. Champion L, Stern M, Israel-Biet D et al (2006) Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Int Med 144:505-510
18. Y Morath C, Schwenger V, Ksoll-Rudek D, Sommerer C, Beimler J, Zeier M (2007) Four cases of sirolimus- associated interstitial pneumonitis: identification of risk factors. Transplant Proc 39:99-102 (Pubitemid 46175977)
19. Sola E, Lopez V, Gutierrez C et al (2010) Late conversion to mammalian target of rapamycin inhibitor/proliferation signal inhibitors in kidney transplant patients: clinical experience in the last 5 years. Transpl Proc 42:2859-2860